These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3247618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Non-Hodgkin's lymphomas. I. Clinico-biological features in a series of 98 patients].
    Tomás JF, San Miguel JF, Martín MJ, Martínez R, Moraleda JM, González M, Cañizo MC, Ojeda E, Ramos F, Flores T.
    Sangre (Barc); 1988 Oct; 33(5):361-6. PubMed ID: 3247617
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K, Maseki N, Sakurai M, Hattori M.
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The grouping of morphological variants of non-Hodgkin's lymphomas (lymphosarcomas) by the degree of malignancy].
    Sotnikov VM, Kharchenko VP, Pan'shin GA, Galil-Ogly GA, Zakharova LV, Teĭblium MM.
    Klin Med (Mosk); 1996 Feb; 74(2):41-3. PubMed ID: 8772102
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H, Hong XN, Li J, Peng LP, Ye L.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors in non-Hodgkin's lymphomas].
    Mayáns J, Sanz G, Monzó E, Sancho-Tello R, Carrera MD, Figueres J, Sanz MA.
    Rev Clin Esp; 1987 May; 180(8):420-5. PubMed ID: 3616025
    [No Abstract] [Full Text] [Related]

  • 8. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL, Magagnoli M, Pagliani G, Bendandi M, Gherlinzoni F, Merla E, Salvucci M, Tura S.
    Haematologica; 1997 May; 82(3):305-8. PubMed ID: 9234576
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of aggressive non-Hodgkin's lymphomas].
    López A, Palacio C.
    Med Clin (Barc); 1998 May 09; 110(16):614-8. PubMed ID: 9656199
    [No Abstract] [Full Text] [Related]

  • 16. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO, Gershanovich ML, Tikhonova VV.
    Vopr Onkol; 2004 May 09; 50(4):421-5. PubMed ID: 15605764
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.